Gilead Sciences (GILD) to Resume Trading at 4:25PM ET Following Strong Results
Get Alerts GILD Hot Sheet
Price: $73.25 +0.33%
Revenue Growth %: -0.5%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
SHIM, KOD, HEWA, More
Revenue Growth %: -0.5%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) set to resume trading at 4:25PM ET following strong Q2 results and outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xilio Therapeutics (XLO) Announces $11.3 Million Private Placement Equity Financing, License Agreement with Gilead (GILD)
- Equity fund flows positive for fifth month, market broadening expected - Barclays
- Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Create E-mail Alert Related Categories
Earnings, Hot Earnings, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!